Assisted Reproductive Service Market in China 2021
The assisted reproductive service market in China in terms of revenue is set to grow by US$ 7 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 14.2% during the forecast period, according to data and analytics company StrategyHelix.
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for assisted reproductive service. The China assisted reproductive service market is segmented on the basis of couple. By couple, it is categorized into assisted reproductive service patients, childbearing couples, and infertile couples.
The report has profiled some of the key players of the market such as Hospital for Reproductive Medicine Affiliated to Shandong University, Jinxin Fertility Group Limited, Peking University Third Hospital, Reproductive & Genetic Hospital of CITIC-Xiangya.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the assisted reproductive service market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Report Scope
Couple: assisted reproductive service patients, childbearing couples, and infertile couples
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the China assisted reproductive service market
Pinpoint growth sectors and trends for investment
Understand what the future of the assisted reproductive service market in China looks like
Identify the competitive landscape and window of opportunity
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for assisted reproductive service. The China assisted reproductive service market is segmented on the basis of couple. By couple, it is categorized into assisted reproductive service patients, childbearing couples, and infertile couples.
The report has profiled some of the key players of the market such as Hospital for Reproductive Medicine Affiliated to Shandong University, Jinxin Fertility Group Limited, Peking University Third Hospital, Reproductive & Genetic Hospital of CITIC-Xiangya.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the assisted reproductive service market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Report Scope
Couple: assisted reproductive service patients, childbearing couples, and infertile couples
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the China assisted reproductive service market
Pinpoint growth sectors and trends for investment
Understand what the future of the assisted reproductive service market in China looks like
Identify the competitive landscape and window of opportunity
1. MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. MARKET DATA & OUTLOOK
3.1 Market Value
3.2 Market Value Forecast
4. ASSISTED REPRODUCTIVE SERVICE MARKET BY COUPLE
4.1 Assisted Reproductive Service Patients
4.2 Childbearing Couples
4.3 Infertile Couples
5. COMPANY PROFILES
5.1 Hospital for Reproductive Medicine Affiliated to Shandong University
5.2 Jinxin Fertility Group Limited
5.3 Peking University Third Hospital
5.4 Reproductive & Genetic Hospital of CITIC-Xiangya
6. APPENDIX
6.1 About StrategyHelix
6.2 Disclaimer
2. RESEARCH METHODOLOGY
3. MARKET DATA & OUTLOOK
3.1 Market Value
3.2 Market Value Forecast
4. ASSISTED REPRODUCTIVE SERVICE MARKET BY COUPLE
4.1 Assisted Reproductive Service Patients
4.2 Childbearing Couples
4.3 Infertile Couples
5. COMPANY PROFILES
5.1 Hospital for Reproductive Medicine Affiliated to Shandong University
5.2 Jinxin Fertility Group Limited
5.3 Peking University Third Hospital
5.4 Reproductive & Genetic Hospital of CITIC-Xiangya
6. APPENDIX
6.1 About StrategyHelix
6.2 Disclaimer
